Page 2241 - Williams Hematology ( PDFDrive )

2216 Part XII: Hemostasis and Thrombosis Chapter 129: Disseminated Intravascular Coagulation 2217

114. Levi M: Current understanding of disseminated intravascular coagulation. Br J Haema- 147. Collins PW, Macchiavello LI, Lewis SJ, et al: Global tests of haemostasis in critically ill
tol 124:567, 2004. patients with severe sepsis syndrome compared to controls. Br J Haematol 135:220-,
115. Siegal T, Seligsohn U, Aghai E, et al: Clinical and laboratory aspects of disseminated 2006.
intravascular coagulation (DIC): A study of 118 cases. Thromb Haemost 39:122, 148. Toh CH, Hoots WK: The scoring system of the Scientific and Standardisation Commit-
1978. tee on Disseminated Intravascular Coagulation of the International Society on Throm-
116. Al-Mondhiry H: Disseminated intravascular coagulation: Experience in a major cancer bosis and Haemostasis: A 5-year overview. J Thromb Haemost 5:604, 2007.
center. Thromb Diath Haemorrh 34:181, 1975. 149. Bone RC: Modulators of coagulation. A critical appraisal of their role in sepsis. Arch
117. Hofstra JJ, Haitsma JJ, Juffermans NP, et al: Role of broncho-alveolar hemostasis in the Intern Med 152:1381, 1992.
pathogenesis of acute lung injury. Semin Thromb Hemost 34:475, 2008. 150. Keller TT, Mairuhu AT, de Kruif MD, et al: Infections and endothelial cells. Cardiovasc
118. Rinaldo JE, Rogers RM: Adult respiratory distress syndrome [editorial]. N Engl J Med Res 60:40, 2003.
315:578, 1986. 151. Gando S, Nanzaki S, Sasaki S, et al: Activation of the extrinsic coagulation pathway in
119. Katsumura Y, Ohtsubo K: Incidence of pulmonary thromboembolism, infarction and patients with severe sepsis and septic shock. Crit Care Med 26:2005, 1998.
hemorrhage in disseminated intravascular coagulation. Thorax 50:160, 1995. 152. Wiersinga WJ, Meijers JC, Levi M, et al: Activation of coagulation with concurrent
120. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 332:27, impairment of anticoagulant mechanisms correlates with a poor outcome in severe
1995. melioidosis. J Thromb Haemost 6:32, 2008.
121. Dhainaut JF, Shorr AF, Macias WL, et al: Dynamic evolution of coagulopathy in the 153. Bone RC: Gram-positive organisms and sepsis. Arch Intern Med 154:26, 1994.
first day of severe sepsis: Relationship with mortality and organ failure. Crit Care Med 154. Levi M, van der Poll T: Coagulation in sepsis: All bugs bite equally. Crit Care 8:99, 2004.
33:341, 2005. 155. Herwald H, Cramer H, Morgelin M: M-protein, a classical bacterial virulence deter-
122. Spero JA, Lewis JH, Hasiba U: Disseminated intravascular coagulation. Findings in 346 minant forms complexes with fibrinogen that induce vascular leakage. Cell 116:367,
patients. Thromb Haemost 43:28, 1980. 2004.
123. Bakhtiari K, Meijers JC, de Jonge E, et al: Prospective validation of the international 156. Fijnvandraat K, Derkx B, Peters M, et al: Coagulation activation and tissue necrosis in
society of thrombosis and haemostasis scoring system for disseminated intravascular meningococcal septic shock: Severely reduced protein C levels predict a high mortality.
coagulation. Crit Care Med 32:2416, 2004. Thromb Haemost 73:15, 1995.
124. Dhainaut JF, Yan SB, Joyce DE, et al: Treatment effects of drotrecogin alfa (activated) in 157. Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, et al: Age-related differences in out-
patients with severe sepsis with or without overt disseminated intravascular coagula- come and severity of DIC in children with septic shock and purpura. Thromb Haemost
tion. J Thromb Haemost 2:1924, 2004. 76:932, 1996.
125. Dempfle CE, Pfitzner SA, Dollman M, et al: Comparison of immunological and func- 158. Levi M, Opal SM: Coagulation abnormalities in critically ill patients. Crit Care 10:222,
tional assays for measurement of soluble fibrin. Thromb Haemost 74:673, 1995. 2006.
126. Bredbacka S, Blomback M, Wiman B, et al: Laboratory methods for detecting dissem- 159. Levi M: Hemostasis and thrombosis in critically ill patients. Semin Thromb Hemost
inated intravascular coagulation (DIC): New aspects. Acta Anaesthesiol Scand 37:125, 34:415, 2008.
1993. 160. Ono T, Mimuro J, Madoiwa S, et al: Severe secondary deficiency of von Willebrand
127. Bredbacka S, Blomback M, Wiman B: Soluble fibrin: A predictor for the development factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated
and outcome of multiple organ failure. Am J Hematol 46:289, 1994. intravascular coagulation: Its correlation with development of renal failure. Blood
128. McCarron BI, Marder VJ, Kanouse JJ, et al: A soluble fibrin standard: Comparable 107:528, 2006.
dose-response with immunologic and functional assays. Thromb Haemost 82:145, 1999. 161. Bhakdi S, Muhly M, Mannhardt U: Staphylococcal alpha toxin promotes blood coagu-
129. Shorr AF, Thomas SJ, Alkins SA, et al: D-dimer correlates with proinflammatory cytok- lation via attack on human platelets. J Exp Med 168:527, 1988.
ine levels and outcomes in critically ill patients. Chest 121:1262, 2002. 162. Ratnoff OD, Nebehay WG: Multiple coagulative defects in a patient with the Water-
130. Dempfle CE: The use of soluble fibrin in evaluating the acute and chronic hypercoag- house-Friderichsen syndrome. Ann Intern Med 56:627, 1962.
ulable state. Thromb Haemost 82:673, 1999. 163. van Gorp E, Suharti C, ten Cate H, et al: Review: Infectious diseases and coagulation
131. Horan JT, Francis CW: Fibrin degradation products, fibrin monomer and soluble fibrin disorders. J Infect Dis 180:176, 1999.
in disseminated intravascular coagulation. Semin Thromb Hemost 27:657, 2001. 164. Levi M, Keller TT, van Gorp E, et al: Infection and inflammation and the coagulation
132. McCarron BI, Marder VJ, Francis CW: Reactivity of soluble fibrin assays with plasmic system. Cardiovasc Res 60:26, 2003.
degradation products of fibrin and in patients receiving fibrinolytic therapy. Thromb 165. Heller MV, Marta RF, Sturk A, et al: Early markers of blood coagulation and fibrinolysis
Haemost 82:1722, 1999. activation in Argentine hemorrhagic fever. Thromb Haemost 73:368, 1995.
133. Carr JM, McKinney M, McDonagh J: Diagnosis of disseminated intravascular coagula- 166. Clemens R, Pramoolsinsap C, Lorenz R, et al: Activation of the coagulation cascade in
tion. Role of D-dimer. Am J Clin Pathol 91:280, 1989. severe falciparum malaria through the intrinsic pathway. Br J Haematol 87:100, 1994.
134. Boisclair MD, Ireland H, Lane DA: Assessment of hypercoagulable states by measure- 167. Mohanty D, Ghosh K, Nandwani SK, et al: Fibrinolysis, inhibitors of blood coagulation,
ment of activation fragments and peptides. Blood Rev 4:25, 1990. and monocyte derived coagulant activity in acute malaria. Am J Hematol 54:23, 1997.
135. Prisco D, Paniccia R, Bonechi F, et al: Evaluation of new methods for the selective mea- 168. Fera G, Semeraro N, De MV, et al: Disseminated intravascular coagulation associated
surement of fibrin and fibrinogen degradation products. Thromb Res 56:547, 1989. with disseminated cryptococcosis in a patient with acquired immunodeficiency syn-
136. Shorr AF, Trotta RF, Alkins SA, et al: D-dimer assay predicts mortality in critically drome. Infection 21:171, 1993.
ill patients without disseminated intravascular coagulation or venous thromboembolic 169. Cosgriff TM: Viruses and haemostasis. Rev Infect Dis 11:672, 1989.
disease. Intensive Care Med 25:207, 1999. 170. Inbal A, Kenet G, Zivelin A, et al: Purpura fulminans induced by disseminated intra-
137. Greenberg CS, Devine DV, McCrae KM: Measurement of plasma fibrin D-dimer levels vascular coagulation following infection in 2 unrelated children with double heterozy-
with the use of a monoclonal antibody coupled to latex beads. Am J Clin Pathol 87:94, gosity for factor V Leiden and protein S deficiency. Thromb Haemost 77:1086, 1997.
1987. 171. Hofstra JJ, Schouten M, Levi M: Thrombophilia and outcome in severe infection and
138. Taylor FB Jr, Toh CH, Hoots WK, et al: Towards definition, clinical and laboratory crite- sepsis. Semin Thromb Hemost 33:604, 2007.
ria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 172. Levin M, Eley BS, Louis J: Postinfectious purpura fulminans caused by an autoantibody
86:1327, 2001. directed against protein S. J Pediatr 127:355, 1995.
139. Kobayashi S, Gando S, Morimoto Y: Serial measurement of arterial lactate concentra- 173. Bhamarapravati N: Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis 11
tions as a prognostic indicator in relation to the incidence of disseminated intravascular Suppl 4:S826, 1989.
coagulation in patients with systemic inflammatory response syndrome. Surg Today 174. Suvatte V: Dengue hemorrhagic fever: Hematological abnormalities and pathogenesis.
31:853, 2001. J Med Assoc Thai 61 Suppl 3:53, 1978.
140. Wada H, Gabazza EC, Asakura H, et al: Comparison of diagnostic criteria for dissemi- 175. Linder M, Muller-Berghaus G, Lasch HG, et al: Virus infection and blood coagulation.
nated intravascular coagulation (DIC): Diagnostic criteria of the International Society Thromb Diath Haemorrh 23:1, 1970.
of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for 176. Carpenter CT, Kaiser AB: Purpura fulminans in pneumococcal sepsis: Case report and
overt DIC: Am J Hematol 74:17, 2003. review. Scand J Infect Dis 29:479, 1997.
141. Kinasewitz GT, Zein JG, Lee GL, et al: Prognostic value of a simple evolving DIC score 177. Gerson WT, Dickerman JD, Bovill EG, et al: Severe acquired protein C deficiency in
in patients with severe sepsis. Crit Care Med 33:2214, 2005. purpura fulminans associated with disseminated intravascular coagulation: Treatment
142. Levi M, van der Poll T, de Jonge E, et al: Relative insufficiency of fibrinolysis in dissem- with protein C concentrate. Pediatrics 91:418, 1993.
inated intravascular coagulation. Sepsis 3:103, 2000. 178. Tishler M, Abramov AL, Seligsohn U, et al: Purpura fulminans in an adult. Isr J Med Sci
143. Liaw PC, Ferrell G, Esmon CT. A monoclonal antibody against activated protein C 22:820, 1986.
allows rapid detection of activated protein C in plasma and reveals a calcium ion depen- 179. Bramson HE, Katz J, Marble R, et al: Inherited protein C deficiency and a coumarin
dent epitope involved in factor Va inactivation. J Thromb Haemost 1:662, 2003. responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 2:1156,
144. Moore JC, Hayward CP, Warkentin TE, et al: Decreased von Willebrand factor protease 1983.
activity associated with thrombocytopenic disorders. Blood 98:1842, 2001. 180. Seligsohn U, Berger A, Abend M: Homozygous protein C deficiency manifested by
145. Levi M, Lowenberg EC: Thrombocytopenia in critically ill patients. Semin Thromb massive venous thrombosis in the newborn. N Engl J Med 310:559, 1984.
Hemost 34:417, 2008. 181. Goad KE, Gralnick HR: Coagulation disorders in cancer. Hematol Oncol Clin North Am
146. Dempfle CE, Borggrefe M: Point of care coagulation tests in critically ill patients. Semin 10:457, 1996.
Thromb Hemost 34:445, 2008. 182. Levi M: Cancer and DIC: Haemostasis 31 Suppl 1:47, 2001.

Kaushansky_chapter 129_p2199-2220.indd 2216 17/09/15 3:46 pm